Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Iltamiocel by Cook MyoSite for Fecal Incontinence: Likelihood of Approval
Iltamiocel is under clinical development by Cook MyoSite and currently in Phase III for Fecal Incontinence. According to GlobalData, Phase...
Data Insights
Iltamiocel by Cook MyoSite for Dysphagia: Likelihood of Approval
Iltamiocel is under clinical development by Cook MyoSite and currently in Phase III for Dysphagia. According to GlobalData, Phase III...